Skip to content
MARKETS / NASDAQ / SBRA
NASDAQ · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP

Sabra Health Care Reit, Inc. SBRA

15 fiscal years on record · USD · FY2025 reported · SEC filings only
$356.9M
▲ 25.4% YoY
$155.6M
▲ 22.8% YoY
$-104.3M
▼ 159.9% YoY
In brief

What this company does

The company operates as a self-administered, self-managed REIT that, through its subsidiaries, acquires, finances and owns real estate leased to third-party tenants in the healthcare sector. It primarily generates revenues by leasing properties to tenants and owning properties operated by third-party property managers throughout the United States and Canada. As of December 31, 2025, the company employed 58 full-time employees, including its executive officers. It operates through an umbrella partnership structure in which substantially all of its properties and assets are held by Sabra Health Care Limited Partnership, a Delaware limited partnership, of which it is the sole general partner. Its investment portfolio is comprised of skilled nursing/transitional care facilities, senior housing communities leased to third-party operators, senior housing communities operated by third-party property managers, behavioral health facilities, specialty hospitals and other facilities, investments in joint ventures, loans receivable, and preferred equity investments. As of December 31, 2025, its investment portfolio consisted of 360 real estate properties held for investment, 13 investments in loans receivable, four preferred equity investments and two investments in unconsolidated joint ventures.

Written from the business description in Sabra Health Care REIT, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 12 February 2026. Every sentence was checked against that document before publication.

Growth
USD 356.9M
Revenue, FY2025 · full 15-year series below
Revenue $M Net income $M
FY2025 · Revenue 356.9 · Net income 155.6
200M-40M-80M20112013201520172019202120232025
Compound annual growth
+24.1%
+18.0%
+4.1%
+2.4%
+7.0%
−0.9%
+0.0%
−2.3%
+1.5%
+0.8%
+10.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +18.0% a year over five years — but profit grew slower: net income at +2.4%, earnings per share at −0.9%.

The share count rose from 0.21B to 0.25B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
44 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating — · Net 43.6%
200%400%600%-20%-40%-60%20112013201520172019202120232025
ROE
FY2025 · ROE 5.6%
5%-1%-2%-3%20112013201520172019202120232025

Each USD of equity produced 6 cents of profit this year.

Cash & shareholders
USD 289.5M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -104.3
200.0M-250.0M-500.0M20112013201520172019202120232025
Net buybacks $M Dividends $M
FY2025 · Dividends 289.5 · Net buybacks —
200M20112013201520172019202120232025

USD 289.5M in dividends — 186% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 5.5B
EquityUSD 2.8B
CashUSD 71.5M
Gross debtUSD 2.5B
Net debtUSD 2.5B

Net debt stands at 87% of equity.

The 15-year record
15 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220212020201920182017201620152014201320122011
Revenue $B0.40.30.20.20.20.20.10.10.00.30.20.20.10.10.1
Operating income $B·····0.20.10.30.20.10.1···0.0
EBITDA $B·····0.30.30.50.30.10.1···0.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Net income $B0.20.10.0−0.1−0.10.10.10.30.20.10.10.00.00.00.0
Free cash flow $B−0.10.20.20.20.30.30.30.1−0.30.0−0.3−0.7−0.1−0.1−0.2
EPS, diluted $0.640.540.06−0.34−0.520.670.371.511.400.921.110.780.680.520.43
Dividend / sh $1.201.201.201.201.201.351.801.801.731.671.601.511.361.320.96
Payout %1862212017−357−232201486117115170138174172251246
ROE %5.64.60.5−2.4−3.34.02.08.47.16.88.06.78.86.23.9
Shares out B0.250.240.230.230.230.210.210.180.180.070.070.060.040.040.04

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 45 reconciliationsAUDITED

Reconciled in 15 of 19 fiscal years. 17 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityReal Estate Investment Trusts
Listed onNASDAQ
Incorporated inMaryland
Fiscal year endsDecember 31
Data on record since2011

Share this section

Download image